Lipoproteins in diabetes mellitus / Alicia J. Jenkins, Peter P. Toth, editors.
Jenkins, Alicia J., editor.; Toth, Peter P., editor.
2023
RC660
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Lipoproteins in diabetes mellitus / Alicia J. Jenkins, Peter P. Toth, editors.
Edition
Second edition.
ISBN
9783031266812 (electronic bk.)
3031266811 (electronic bk.)
9783031266805
3031266803
DOI
https://doi.org/10.1007/978-3-031-26681-2
Published
Cham : Humana Press, [2023]
Copyright
©2023
Language
English
Description
1 online resource (xx, 926 pages) : illustrations (chiefly color).
Item Number
10.1007/978-3-031-26681-2 doi
Call Number
RC660
Dewey Decimal Classification
616.4/62
Summary
Diabetes mellitus has become epidemic on a global scale, and millions of new cases are diagnosed every year. With an estimated 80% of people with diabetes living in disadvantaged regions, and the key roles of lipoproteins in the pathogenesis of the chronic complications of diabetes, this volume will be relevant to many readers globally. It is our intention that the contents will advance knowledge of the readers who will use it to contribute to the reduction of the burden associated with altered lipoproteins in people with diabetes. The second edition of this book provides an updated and comprehensive review of the field. The book, which includes many tables and figures, is presented in three main sections: (i) Lipoprotein metabolism, qualitative changes and measurements; (ii) Lipoproteins and the complications of diabetes; and (iii) the treatment of lipoproteins in diabetes. Each chapter from the first edition has been updated, and new topics added. New topics include the links between glycemia and lipoproteins, the role of lipoproteins in ischemic stroke, the diagnosis and management of statin intolerance (which is thought to be more common in people with diabetes) and the use of PCSK9 inhibitors and fish oils in the management of lipoproteins in people with diabetes. This book is written by an international group of experts in the clinical, laboratory and research aspects of lipoproteins in diabetes. Lipoproteins in Diabetes Mellitus, 2nd Edition is a comprehensive reference on the clinical and scientific aspects of lipoproteins in diabetes. It is a must-have resource for primary care and specialist clinicians, clinical and basic science researchers and to trainees and students.
Note
Includes index.
Access Note
Access limited to authorized users.
Source of Description
Description based on print version record.
Added Author
Jenkins, Alicia J., editor.
Toth, Peter P., editor.
Series
Contemporary diabetes.
Available in Other Form
Lipoproteins in diabetes mellitus.
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Part 1 : Lipoprotein Metabolism, Qualitative Changes and Measurements
1. Laboratory Assessment of Lipoproteins in Type 2 Diabetes
2. Tools for Assessing Lipoprotein Metabolism in Diabetes Mellitus
3. Links Between Glucose and Lipoproteins
4. Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes
5. Lipoprotein metabolism and alterations induced by insulin resistance and diabetes
6. The PPAR system in diabetes
7. Production And Metabolism Of Triglyceride-Rich Lipoproteins: Impact Of Diabetes
8. Triglyceride- And Cholesterol-Rich Remnant Lipoproteins In Risk Of Cardiovascular Disease In Diabetes Mellitus
9. HDL Function In Diabetes
10. Lipoprotein (a): Metabolism, Pathophysiology and Impact on Diabetes Mellitus
11. Lipoprotein Glycation in Diabetes Mellitus
12. Lipid:Extracellular Matrix Interactions as Therapeutic Targets in the Atherosclerosis of Diabetes
Part 2 : Lipoproteins and the Complications of Diabetes
13. The Role of Modified Forms of LDL and Corresponding Autoantibodies in the Development of Complications in Diabetes
14. Endothelial dysfunction in type 2 diabetes, with an update on new interventions
15. Lipoproteins and diabetic kidney disease
16. Lipids and Diabetic Retinopathy
17. Roles of Extravasated and Modified Plasma Lipoproteins in Diabetic Retinopathy
18. The Role Of Lipids And Lipoproteins In Peripheral Neuropathy
19. Lipoproteins and Ischemic Stroke in Diabetes
Part 3 : Lipoprotein Treatment in Diabetes
20. About Randomized Clinical Trials Related to Lipoproteins in Diabetes Mellitus
21. Effects of Lifestyle (Diet, Plant Sterols, Exercise and Smoking) and Glycemic Control on Lipoproteins in Diabetes
22. Statin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes
23. Statin intolerance An overview for clinicians
24. Fibrate Therapy: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes Mellitus Type 2
25. EPA and Mixed Omega-3 Fatty Acids: Impact on Dyslipidemia and Cardiovascular Events in Patients With Diabetes
26. Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus
27. Clinical Efficacy Of Proprotein Convertase Synthase Kexin Type 9 Inhibition In Persons With Diabetes Mellitus
28. Clinical Care of Lipids in People with Type 1 diabetes
29. Adjunct drug treatment to reduce vascular disease in people with diabetes
30. Emerging lipoprotein-related therapeutics for patients with diabetes
Part 4 : Epidemiology of Diabetes and Diabetic Dyslipidemia
31. Diabetes Epidemiology And Its Implications
32. Epidemiology, Control, and Cardiovascular Outcomes of Dyslipidemia in Diabetes.

Browse Subjects

Show more subjects...

Statistics

from
to
Export